Bristol-Myers Squibb Sues Apotex

  • November 29, 2011

Bristol-Myers Squibb filed suit against Apotex over four patents related to cyclic protein tyrosine kinase inhibitors.  11/23, District of New Jersey, 3:2011cv06918.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×